Sreekumar R Kodangattil

This inventor holds 6 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Pfizer Corporation, Boston Medical Center Corporation, The Brigham and Women's Hospital, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sreekumar R Kodangattil. Retrieved from https://idiyas.com/inventor/sreekumar-r-kodangattil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Boston Medical Center Corporation

patents

3 out of 1,428

The Brigham and Women's Hospital, Inc.

patents

where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448439 - Interferon beta antibodies and uses thereof (2025-10-21),

2. 11970524 - Recombinant ROBO2 proteins, compositions, methods and uses thereof (2024-04-30),

3. 11858986 - Interferon beta antibodies and uses thereof (2024-01-02),

4. 11365253 - Anti-ROBO2 antibodies, compositions, methods and uses thereof (2022-06-21),

5. 10906955 - Recombinant ROBO2 proteins, compositions, methods and uses thereof (2021-02-02),

6. 10829553 - Interferon beta antibodies and uses thereof (2020-11-10),

Title: Innovations and Contributions of Sreekumar R Kodangattil

Introduction

Sreekumar R Kodangattil is a notable inventor based in Lexington, MA, with a significant contribution to the field of biotechnology. He holds a total of six patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents is the invention titled "Interferon beta antibodies and uses thereof." This invention relates to antibodies, or antigen-binding fragments thereof, that specifically bind to interferon beta (IFNβ). Such antibodies are useful for various therapeutic or diagnostic purposes. Another significant patent is for "Recombinant ROBO2 proteins, compositions, methods and uses thereof." This invention provides recombinant Roundabout Receptor 2 (ROBO2) proteins designed to bind SLIT ligands and prevent their binding to ROBO2 cell surface receptors. The patent also includes methods for the use of these recombinant ROBO2 proteins.

Career Highlights

Sreekumar has worked with prominent organizations, including Pfizer Corporation and The Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.

Collaborations

He has collaborated with esteemed colleagues such as Stefano V Gulla and Janet Elizabeth Buhlmann, further enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Sreekumar R Kodangattil's innovative contributions and patents reflect his commitment to advancing healthcare through biotechnology. His work continues to influence therapeutic and diagnostic methods, making a significant impact in the field.

Profile summary based on public USPTO records.